Unibest

Pharmaceutical intermediates

Fexuprazan HCl Intermediates

2 pharmaceutical intermediates for Fexuprazan HCl. Indication: Erosive esophagitis; Gastroesophageal reflux disease.

提交项目All intermediates

About Fexuprazan HCl

Originator
Daewoong Pharmaceutical Co., Ltd
Indication
Erosive esophagitis; Gastroesophageal reflux disease

Available intermediates

2 intermediates currently listed for Fexuprazan HCl. Request specifications, documentation or a quotation for any item below.

Fexuprazan HCl intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
methyl 5-(2,4-difluorophenyl)-4-methoxy-1H-pyrrole-3-carboxylate1902955-29-6//
3-Fluorobenzenesulfonyl chloride701-27-9//

Other programs under F

FebuxostatFezolinetantFilgotinib MaleateFinerenoneFluralanerFostamatinib disodium hexahydrateFruquintinibFutibatinib

Building toward Fexuprazan HCl?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

提交项目 联系团队

我们能如何帮助您？

获取最新活动与法规动态洞察

直接发送到您的邮箱

在此获取行业洞察与 Unibest 动态

联系我们 →